Company Statement: Cephalon shareholders approve acquisition by Teva
MLex Summary: Biopharmaceutical company Cephalon announced that its shareholders have approved Teva's offer. The tie-up still requires clearances from the European Commission and the US's Federal Trade Commission.The full statement follows:...To view the full article, register now.
Already a subscriber? Click here to view full article